Wearable blood-sugar monitors deliver round-the-clock glucose readings—and relief from the daily grind of finger-stick blood tests
A continuous sensor points out often-neglected, sometimes dangerous blood-sugar spikes, but critics question its usefulness to the well.
Want to make a billion dollars? Here’s a hot tip: Invent wearable technology that detects diabetes, measures glucose levels, and determines how much insulin is needed – all without the need for a single drop of blood.
A new crop of digital health companies is using blood glucose monitors to transform the way we eat.
mHealth and telehealth advocates have long sought to use technology to identify those people and put them on a healthier path before they either develop diabetes or experience adverse health outcomes because of poor health management.
This review aims to offer an up-to-date report on the leading technologies for non-invasive (NI) and minimally-invasive (MI) glucose monitoring sensors, devices currently available in the market, regulatory framework for accuracy assessment, new approaches currently under study by representative groups and developers, and algorithm types for signal enhancement and value prediction.
In this article I’m going to introduce a simple technique that, when used properly, is one of the most effective ways to maintain healthy blood sugar and prevent cardiovascular and metabolic disease – without unnecessary drugs.
The FreeStyle Libre, made by Abbott, is a flash glucose sensor that allows people with diabetes to view our blood sugar every minute of the day without a single finger prick. While there are similar devices on the market — called continuous glucose monitors, or CGMs — the Libre is the least invasive one I’ve seen.
Now, as consumer gadgets weave themselves ever more tightly into everyday life, patients and their families are finding homespun solutions to problems medical-device manufacturers originally did not address. Industry executives say the pace of user-driven innovation was one reason the Food and Drug Administration recently reclassified remote glucose-monitoring devices, hastening approval for new models by big companies like Dexcom and Medtronics.
Rumors are flying that Apple is developing some kind of wearable that would continuously track the user’s blood sugar without breaking their skin. For people with diabetes, this would be a huge improvement over the somewhat invasive or downright painful options they currently rely on. But experts warn that if the rumors are true, Apple will be facing a scientific and technological battlefield littered with decades of other companies’ failures.
“As well as being a replacement for finger-prick testing,” Jose explains, “this technology opens up the potential for people with diabetes to receive continuous readings, meaning they are instantly alerted when intervention is needed.”
People living with diabetes have to prick their fingers to check their blood sugar levels anywhere from one to seven times a day. But now, there’s a better way to monitor blood sugar. This week, the US Food and Drug Administration approved the first at-home, needleless system for continuously monitoring glucose for people with diabetes. The system, called FreeStyle Libre Flash, and manufactured by the DC-based Abbott Laboratories, allows users to forgo finger-pricking for up to 10 days at a time.
A new generation of devices promises an easier way to measure blood sugar in people with diabetes—and in doing so reduce the chances that the disease will lead to long-term complications.
While these devices offer a glimpse into an exciting future—eventually the monitors may be able to automatically adjust insulin pump doses, operating as a kind of mechanical pancreas—a few major obstacles remain in the short term.
Companies work on artificial pancreas, but approval process is too long for many patients.
Diabetes has forced me to become a self-tracker, and I can't stand it.
While not everyone is ready to hand over the reins of their insulin pump to a DIY piece of software, there are a great many who want to be able work with their own data, but aren't allowed because device manufacturers won't open up their APIs or make the data available to download.
Dana Lewis texted her pancreas on Thursday. Of course, the text wasn't the typical "Hey, what's up?" or "You free tonight?" Instead, it was a command to give her blood's glucose level a little boost - she needed to give herself a bit of a buffer ahead of a big speech.
For some of the patients I spoke to, the new Medtronic device doesn’t go far enough. They said it’s too cumbersome and still requires a lot of vigilance on the part of patients. "In the long term," Wedding added, "the best thing would be a cure."
Make CGM use a little easier with these suggestions.
Time in range, a new metric for people with diabetes, would have made no sense to those living with this disease 75 years ago because they rarely, if ever, knew what their blood sugar level was at a particular moment.
The technology that helps people manage diabetes has gotten so good that patients sometimes feel trapped without it.
If you're considering switching to a continuous glucose monitor, try one of these.
Choosing a Continuous Glucose Monitor is a big decision. Here we breakdown the top CGMs, their manufacturers, and features so you can select the right CGM to fit your lifestyle.
With the Dexcom G5™ Mobile app, you’ll have the world’s first continuous glucose monitoring system on your smart device. You can view your real-time glucose data and trends right on your phone and share your data with loved ones and caregivers.
Eversense is the first and only long-term implantable CGM with a sensor that lasts up to 90 days AND has a removable transmitter.
Diabetes is complex enough. Monitoring your diabetes shouldn’t be.
GlySens Incorporated is a privately held corporation devoted to developing the world’s first truly long term continuous glucose monitoring system, intended to dramatically improve the lives of people with diabetes. The GlySens fully implanted sensor—demonstrated up to 18 month lifetime in preclinical testing—wirelessly links to a convenient external receiver,
Medtronic is the only company that offers standalone CGM and sensor-integrated pump therapy, which streamlines the process for optimal customer experience. Other CGM companies do not offer an integrated system, requiring an insulin pump from a different company.
Wearing a CGM (continuous glucose monitor) and Heart Rate Monitor, our advanced AI will give you personalized advice on how to stay in check.
Levels tracks your blood glucose in real time, so you can maximize your diet and exercise.
The glucose sensor is easy and pain-free to apply.
The Nightscout Foundation exists to encourage and support the creation of open source technology projects that enhance the lives of people with Type 1 Diabetes and those who love them. This includes fundraising, advocacy, and direct software and hardware development.
CGM in the Cloud is a group for those to share their experiences with open source solutions to send data from the Dexcom G4 to the cloud so that it can be accessed anywhere...so our kids/friends/parents can be monitored while they are in another room, in another state, at a play date, sleepover, sports activity, or even at school.